Tarsus Pharmaceuticals TARS
NASDAQ TARS
$76.75 -0.06 (-0.08%)
As of: Sep 29, 2026 · 3:59 PM EDT

Tarsus Pharmaceuticals (TARS) Receivables (2020 - 2026)

Updated

Tarsus Pharmaceuticals' Receivables was $98.31 million in Q2 2026, up 63.2% from $60.24 million a year earlier but down 16.1% from the prior quarter.

Analysis

Tarsus Pharmaceuticals (TARS) Receivables (2020 - 2026) Analysis & Trends

At the end of FY2025, Receivables at Tarsus Pharmaceuticals came in at $87.11 million, up 81.3% from FY2024.

  • Receivables has now increased for three consecutive years, with a five-year compound annual growth rate of 434.3% (FY2020 to FY2025).
  • In earlier years, Receivables was $48.06 million in FY2024 (+171.3%), $17.71 million in FY2023 (+394.5%), $3.58 million in FY2022 and $92,000 in FY2021 (+360.0%).
  • Quarterly Receivables has moved between $92,000 (Q4 2021) and $117.21 million (Q1 2026) over five years.
  • Compared with a year earlier, Receivables has increased for eight straight quarters, with growth averaging 139.9% over the last eight quarters.
  • The best year-over-year quarter for Receivables over five years was Q1 2024 (growth of 974.7%); the worst was Q1 2022 (a decline of 99.0%).
  • Per Business Quant data, TARS's Receivables in the three quarters before Q2 2026 was $117.21 million (Q1 2026), $87.11 million (Q4 2025) and $74.34 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 19.05 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 13.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.56 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 9.64 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.68 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.23 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 5.06 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 12.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.13 Bn
10 Tarsus Pharmaceuticals 3.32 Bn 2.27 Bn 161.80 Mn 98.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 98.31 Mn
Mar 31, 2026 117.21 Mn
Dec 31, 2025 87.11 Mn
Sep 30, 2025 74.34 Mn
Jun 30, 2025 60.24 Mn
Mar 31, 2025 64.15 Mn
Dec 31, 2024 48.06 Mn
Sep 30, 2024 30.30 Mn
Jun 30, 2024 30.84 Mn
Mar 31, 2024 31.36 Mn
Dec 31, 2023 17.71 Mn
Sep 30, 2023 6.37 Mn
Mar 31, 2023 2.92 Mn
Dec 31, 2022 3.58 Mn
Sep 30, 2022 4.01 Mn
Jun 30, 2022 620,000.00
Mar 31, 2022 323,000.00
Dec 31, 2021 92,000.00
Jun 30, 2021 20.16 Mn
Mar 31, 2021 32.20 Mn
API Access

Tarsus Pharmaceuticals Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=TARS&period=max&api_key=YOUR_API_KEY